SVG Sprites

Press

LDPN in the News 08.25.2020

Elizabeth Warren, others seek details of Warp Speed co-chief Moncef Slaoui’s contract

Washington Post – 8/25/20

“The HHS Office of Inspector General, responding to a complaint by the advocacy groups Public Citizen and Lower Drug Prices Now, said in July that Slaoui would be in his post for longer than 130 days, which did not qualify him as a “special government employee,” a designation that would have required him to make financial disclosures and follow conflict-of-interest rules.”

LDPN in the News 08.06.2020

HEALTH CARE BRIEFING: School Reopening Push Gets Panel Scrutiny

Bloomberg – 8/6/20

Meanwhile, two consumer groups yesterday filed complaints with a federal government watchdog questioning the role of the White House’s Covid-19 vaccine czar. Public Citizen and Lower Drug Prices Now filed two complaints with the HHS Office of the Inspector General asking about Moncef Slaoui’s role guiding vaccine development and whether he may be subject to the same conflict of interest requirements as government employees. Slaoui was the head of GlaxoSmithKline’s vaccines department and maintains millions of dollars in company stock. 

LDPN in the News 08.05.2020

Pharma CEOs privately scoff at Trump’s drug pricing executive orders: “Not expecting any impact”

Salon – 8/5

“These Executive Orders are not about policy, they’re about politics,” Margarida Jorge, the campaign director for Lower Drug Prices Now, told the Post. “The only reason for President Trump’s rekindled interest in lowering drug prices is his dwindling poll numbers, and realization that our country’s senior citizens are abandoning him thanks to his bungled handling of the coronavirus crisis.”

LDPN in the News 08.03.2020

Opinion | Expect Little From Trump’s Drug-Price Move

Wall Street Journal – 8/3/20

LDPN in the News 07.31.2020

Vaccine project contract raises transparency questions

Politico – 7/31/20

Executives with pharma ties are exempt from disclosing conflicts.

The Trump administration is hiring consultants with drug industry ties to steer its effort to find a coronavirus vaccine under a contract that allows them to avoid disclosing potential conflicts of interest.

LDPN in the News 07.24.2020

Trump signs executive orders aimed at lowering drug prices in largely symbolic move

Washington Post – 7/24/20 

One advocacy group pushing lower drug prices panned the orders as an empty political gesture shortly after Trump’s signing ceremony.

“These Executive Orders are not about policy, they’re about politics,” said Margarida Jorge, campaign director for Lower Drug Prices Now. “The only reason for President Trump’s rekindled interest in lowering drug prices is his dwindling poll numbers, and realization that our country’s senior citizens are abandoning him thanks to his bungled handling of the coronavirus crisis.”

LDPN in the News 07.18.2020

Vaccine programme co-director will not be required to divulge pharmaceutical ties

The Independent – 7/18/20

“The basic idea that he’s in a really privileged position with lots of resources to command and that he has a personal financial stake in the industry is really challenging,” Margarida Jorge, the campaign director for Lower Drug Prices Now, the second watchdog, told The Times.

“Everyone can appreciate that Dr Slaoui has expertise in the development of vaccines, but expertise and ethics should not be mutually exclusive.”

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles